Literature DB >> 7855184

Facilitation of shuttle-box avoidance behaviour in mice treated with nifedipine in combination with amphetamine.

J Vetulani1, M Battaglia, C Castellano, M Sansone.   

Abstract

The dihydropyridine calcium channel antagonist nifedipine, tested in mice of CD-1, C57BL/6 and DBA/2 strains, at doses of 2.5, 5 and 10 mg/kg IP, had no significant effect on shuttle-box avoidance acquisition. Nifedipine also failed to affect performance retention in CD-1 mice subjected to a one-trial passive avoidance task (step-through). While ineffective alone, nifedipine strongly enhanced the shuttle-box avoidance facilitating action of amphetamine (1 and 2 mg/kg IP) in low performing CD-1 mice. The results indicate that although calcium channel blockers do not affect learning in avoidance paradigms in normal animals, they can interfere with the effects of other centrally acting drugs. Calcium antagonists might interfere with neuronal changes induced by amphetamine, but at present it is difficult to explain the strong avoidance facilitation produced by combinations of nifedipine and amphetamine. A possibility that the action of nifedipine on cerebral circulation is involved in the amphetamine-nifedipine interaction cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7855184     DOI: 10.1007/bf02245700

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Aging and cognition: facilitation of recent memory in aged nonhuman primates by nimodipine.

Authors:  M Sandin; S Jasmin; T E Levere
Journal:  Neurobiol Aging       Date:  1990 Sep-Oct       Impact factor: 4.673

2.  The antiseizure activity of dihydropyridine calcium channel antagonists in the conscious rat.

Authors:  M A Morón; C W Stevens; T L Yaksh
Journal:  J Pharmacol Exp Ther       Date:  1990-03       Impact factor: 4.030

3.  Yawning induced by apomorphine, physostigmine or pilocarpine is potentiated by dihydropyridine calcium channel blockers.

Authors:  A Bourson; P C Moser
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  The behavioral effects of the calcium agonist Bay K 8644 in the mouse: antagonism by the calcium antagonist nifedipine.

Authors:  G T Bolger; B A Weissman; P Skolnick
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

5.  A comparison of calcium antagonists and diazepam in reducing ethanol withdrawal tremors.

Authors:  G H Bone; E Majchrowicz; P R Martin; M Linnoila; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Pharmacological investigations of neurotransmitter involvement in passive avoidance responding: a review and some new results.

Authors:  G Bammer
Journal:  Neurosci Biobehav Rev       Date:  1982       Impact factor: 8.989

7.  Nimodipine improves spatial working memory and elevates hippocampal acetylcholine in young rats.

Authors:  A Levy; R M Kong; M J Stillman; B Shukitt-Hale; T Kadar; T M Rauch; H R Lieberman
Journal:  Pharmacol Biochem Behav       Date:  1991-07       Impact factor: 3.533

8.  Similar effects of nifedipine and hydralazine on anaesthesia and hypermotility induced by pentobarbitone in mice.

Authors:  M Sansone; F Pavone; M Battaglia; W Daniel; J Vetulani
Journal:  J Pharm Pharmacol       Date:  1992-05       Impact factor: 3.765

Review 9.  Catecholamines and aversive learning: a review.

Authors:  T P Oei; M G King
Journal:  Neurosci Biobehav Rev       Date:  1980       Impact factor: 8.989

10.  Effects of calcium antagonists on phencyclidine behaviors.

Authors:  G T Bolger; M F Rafferty; J N Crawley; S M Paul; P Skolnick
Journal:  Pharmacol Biochem Behav       Date:  1986-07       Impact factor: 3.533

View more
  2 in total

1.  L-type voltage-gated calcium channels are required for extinction, but not for acquisition or expression, of conditional fear in mice.

Authors:  Chris K Cain; Ashley M Blouin; Mark Barad
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

2.  Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice.

Authors:  Guy Katz; Assad Khoury; Efrat Kurtzwald; Edith Hochhauser; Eyal Porat; Asher Shainberg; Jonathan G Seidman; Christine E Seidman; Abraham Lorber; Michael Eldar; Michael Arad
Journal:  Heart Rhythm       Date:  2010-07-08       Impact factor: 6.343

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.